ATAI ($ATAI) Insider Trading & Smart Money Activity

ATAI · Biotechnology · Latest filing Jun 26, 2026

$ATAI has 4 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($192.03K), net -$192.03K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$192.03K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

ATAI insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $192.03K 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ATAI insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Gerd KochendoerferChief Operating Officer Sell (Option exercise) 50K sh —
Insider Gerd KochendoerferChief Operating Officer Buy (Option exercise) 50K sh $80K —
Insider Craig Kevin JamesChief Medical Officer Sell (Open-market sale) 10b5-1 42.58K sh $192.03K —
Insider Craig Kevin JamesChief Medical Officer Buy (Option exercise) 42.58K sh $60.82K —

1W / 1M / 6M = how ATAI moved from the trade or filing date.

Insider trading in ATAI: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Gerd Kochendoerfer Chief Operating Officer 2 — Jun 26, 2026
Craig Kevin James Chief Medical Officer 2 -$192.03K Jun 25, 2026

Frequently asked questions

Are ATAI insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $192.03K, a net -$192.03K.

What is the latest insider trade in ATAI?

Gerd Kochendoerfer, Chief Operating Officer filed a sell (option exercise) of 50K sh on Jun 26, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text